New Drugs/Drug News

  • New Drugs/Drug News 2015, Volume 33, No. 3

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    New Products/Product Updates – Winter 2015

  • New Drugs/Drug News 2015, Volume 33, No. 2

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Canagliflozin (Invokana™ - Janssen Inc.) and Dapagliflozin (Forxiga®-AstraZeneca Canada Inc.): New diabetes medications with a novel mechanism of action.

  • New Drugs/Drug News 2015, Volume 33, No. 1

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    New Products/Product Updates – July to December 2014

  • New Drugs/Drug News 2014, Volume 32, No. 3

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Teriflunomide: A New Treatment Alternative for Relapsing-Remitting Multiple Sclerosis

  • New Drugs/Drug News 2014, Volume 32, No. 1/2

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Highlighting New Drugs of 2013

  • New Drugs/Drug News 2013, Volume 31, No. 1/2

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Opioid switching in patients with chronic pain – part 2

  • New Drugs/Drug News 2012, Volume 30, No. 4

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Opioid switching in patients with chronic pain – part 1

  • New Drugs/Drug News 2012, Volume 30, No. 3

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Fidaxomicin (Dificid – Optimer Pharmaceuticals Canada, Inc.):a new antibacterial agent for Clostridium difficile infection

  • New Drugs/Drug News 2012, Volume 30, No. 2

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Clinical Update: Treatment of Acne Vulgaris

Back to top